Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.0K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

462
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
462
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2022
Same author

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels.

Gut pathogens·2020
Same author

TAME trial: a multi-arm phase II randomised trial of four novel interventions for malnutrition enteropathy in Zambia and Zimbabwe - a study protocol.

BMJ open·2019
Same author

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Gastroenterology·2018
Same author

Chapter 5. Fifty Years of Paediatric Gastroenterology.

Journal of pediatric gastroenterology and nutrition·2018
Same author

Chapter 5.1.2. Infectious Diarrhoea.

Journal of pediatric gastroenterology and nutrition·2018

Related Experiment Video

Updated: Mar 19, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Recent Advances in Celiac Disease.

Simon Murch1,2

  • 1Emeritus Professor, Warwick University, Coventry, UK. S.Murch@warwick.ac.uk.

Indian Journal of Pediatrics
|June 10, 2016
PubMed
Summary

Celiac disease diagnosis is improving, with most patients showing milder symptoms. Innate immune responses, particularly IL-15 and encapsulation reactions, play a key role in disease progression.

Keywords:
Celiac diseaseHLA-DQSyndecan-1Tissue transglutaminase

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.2K

Related Experiment Videos

Last Updated: Mar 19, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.2K

Area of Science:

  • Immunology
  • Gastroenterology
  • Pathology

Background:

  • Celiac disease is a common autoimmune disorder.
  • Diagnosis has improved, revealing milder forms of the disease.
  • Mucosal lesions involve both adaptive and innate immune responses.

Purpose of the Study:

  • To explore the immunological mechanisms underlying celiac disease.
  • To investigate the role of innate immunity in disease progression.
  • To discuss diagnostic challenges and potential therapeutic strategies.

Main Methods:

  • Review of current understanding of celiac disease pathogenesis.
  • Analysis of adaptive and innate immune responses, including antibody production (anti-tissue transglutaminase-2, tTG-2) and HLA-DQ genotypes.
  • Discussion of the role of IL-15 and encapsulation reactions.
  • Consideration of animal models and the gut microbiome.
  • Evaluation of diagnostic difficulties in regions with environmental enteropathy.

Main Results:

  • Celiac disease is more common than previously thought, often with subtle symptoms.
  • Both adaptive and innate immunity are crucial for mucosal lesions.
  • Antibody production (tTG-2) depends on HLA-DQ genotypes and gliadin peptide penetration.
  • Innate immune mechanisms, including IL-15, drive disease progression.
  • Encapsulation reactions and syndecan-expressing leukocytes contribute to mucosal changes.
  • Gut microbial flora may influence disease development.
  • Environmental enteropathy complicates histological diagnosis in some regions.

Conclusions:

  • Celiac disease pathogenesis involves complex adaptive and innate immune interactions.
  • IL-15 and encapsulation reactions are key innate immune components.
  • Modulating the gut microbiome may offer therapeutic benefits.
  • High tTG-2 antibody titers are diagnostically significant, especially where enteropathy is prevalent.